Serum levels of oxylipins in achilles tendinopathy: an exploratory study.

BACKGROUND:Linoleic acid-derived oxidation products are found in experimental pain models. However, little is known about the levels of such oxylipins in human pain. In consequence, in the present study, we have undertaken a lipidomic profiling of oxylipins in blood serum from patients with Achilles...

Full description

Bibliographic Details
Main Authors: Sandra Gouveia-Figueira, Malin L Nording, Jamie E Gaida, Sture Forsgren, Håkan Alfredson, Christopher J Fowler
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4395257?pdf=render
_version_ 1818985695620890624
author Sandra Gouveia-Figueira
Malin L Nording
Jamie E Gaida
Sture Forsgren
Håkan Alfredson
Christopher J Fowler
author_facet Sandra Gouveia-Figueira
Malin L Nording
Jamie E Gaida
Sture Forsgren
Håkan Alfredson
Christopher J Fowler
author_sort Sandra Gouveia-Figueira
collection DOAJ
description BACKGROUND:Linoleic acid-derived oxidation products are found in experimental pain models. However, little is known about the levels of such oxylipins in human pain. In consequence, in the present study, we have undertaken a lipidomic profiling of oxylipins in blood serum from patients with Achilles tendinopathy and controls. METHODOLOGY/PRINCIPAL FINDINGS:A total of 34 oxylipins were analysed in the serum samples. At a significance level of P<0.00147 (<0.05/34), two linoleic acid-derived oxylipins, 13-hydroxy-10E,12Z-octadecadienoic (13-HODE) and 12(13)-dihydroxy-9Z-octadecenoic acid (12,13-DiHOME) were present at significantly higher levels in the Achilles tendinopathy samples. This difference remained significant when the dataset was controlled for age, gender and body-mass index. In contrast, 0/21 of the arachidonic acid- and 0/4 of the dihomo-γ-linolenic acid, eicosapentaenoic acid or docosahenaenoic acid-derived oxylipins were higher in the patient samples at this level of significance. The area under the Receiver-Operator Characteristic (ROC) curve for 12,13-DiHOME was 0.91 (P<0.0001). Levels of four N-acylethanolamines were also analysed and found not to be significantly different between the controls and the patients at the level of P<0.0125 (<0.05/4). CONCLUSIONS/SIGNIFICANCE:It is concluded from this exploratory study that abnormal levels of linoleic acid-derived oxylipins are seen in blood serum from patients with Achilles tendinopathy. Given the ability of two of these, 9- and 13-HODE to activate transient receptor potential vanilloid 1, it is possible that these changes may contribute to the symptoms seen in Achilles tendinopathy.
first_indexed 2024-12-20T18:38:59Z
format Article
id doaj.art-a274f06fa0e54ea8895d652d7da38366
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T18:38:59Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a274f06fa0e54ea8895d652d7da383662022-12-21T19:29:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012311410.1371/journal.pone.0123114Serum levels of oxylipins in achilles tendinopathy: an exploratory study.Sandra Gouveia-FigueiraMalin L NordingJamie E GaidaSture ForsgrenHåkan AlfredsonChristopher J FowlerBACKGROUND:Linoleic acid-derived oxidation products are found in experimental pain models. However, little is known about the levels of such oxylipins in human pain. In consequence, in the present study, we have undertaken a lipidomic profiling of oxylipins in blood serum from patients with Achilles tendinopathy and controls. METHODOLOGY/PRINCIPAL FINDINGS:A total of 34 oxylipins were analysed in the serum samples. At a significance level of P<0.00147 (<0.05/34), two linoleic acid-derived oxylipins, 13-hydroxy-10E,12Z-octadecadienoic (13-HODE) and 12(13)-dihydroxy-9Z-octadecenoic acid (12,13-DiHOME) were present at significantly higher levels in the Achilles tendinopathy samples. This difference remained significant when the dataset was controlled for age, gender and body-mass index. In contrast, 0/21 of the arachidonic acid- and 0/4 of the dihomo-γ-linolenic acid, eicosapentaenoic acid or docosahenaenoic acid-derived oxylipins were higher in the patient samples at this level of significance. The area under the Receiver-Operator Characteristic (ROC) curve for 12,13-DiHOME was 0.91 (P<0.0001). Levels of four N-acylethanolamines were also analysed and found not to be significantly different between the controls and the patients at the level of P<0.0125 (<0.05/4). CONCLUSIONS/SIGNIFICANCE:It is concluded from this exploratory study that abnormal levels of linoleic acid-derived oxylipins are seen in blood serum from patients with Achilles tendinopathy. Given the ability of two of these, 9- and 13-HODE to activate transient receptor potential vanilloid 1, it is possible that these changes may contribute to the symptoms seen in Achilles tendinopathy.http://europepmc.org/articles/PMC4395257?pdf=render
spellingShingle Sandra Gouveia-Figueira
Malin L Nording
Jamie E Gaida
Sture Forsgren
Håkan Alfredson
Christopher J Fowler
Serum levels of oxylipins in achilles tendinopathy: an exploratory study.
PLoS ONE
title Serum levels of oxylipins in achilles tendinopathy: an exploratory study.
title_full Serum levels of oxylipins in achilles tendinopathy: an exploratory study.
title_fullStr Serum levels of oxylipins in achilles tendinopathy: an exploratory study.
title_full_unstemmed Serum levels of oxylipins in achilles tendinopathy: an exploratory study.
title_short Serum levels of oxylipins in achilles tendinopathy: an exploratory study.
title_sort serum levels of oxylipins in achilles tendinopathy an exploratory study
url http://europepmc.org/articles/PMC4395257?pdf=render
work_keys_str_mv AT sandragouveiafigueira serumlevelsofoxylipinsinachillestendinopathyanexploratorystudy
AT malinlnording serumlevelsofoxylipinsinachillestendinopathyanexploratorystudy
AT jamieegaida serumlevelsofoxylipinsinachillestendinopathyanexploratorystudy
AT stureforsgren serumlevelsofoxylipinsinachillestendinopathyanexploratorystudy
AT hakanalfredson serumlevelsofoxylipinsinachillestendinopathyanexploratorystudy
AT christopherjfowler serumlevelsofoxylipinsinachillestendinopathyanexploratorystudy